NPPB and hydrops fetalis: Despite the almost exclusive focus on B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP), many biomarkers reflecting different elements of HF pathophysiology exist [11], and the identification of specific biomarkers for each drug has been proposed [12].